Literature DB >> 25320243

The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia.

Joni Van der Meulen1, Viraj Sanghvi2, Konstantinos Mavrakis2, Kaat Durinck1, Fang Fang3, Filip Matthijssens1, Pieter Rondou1, Monica Rosen3, Tim Pieters4, Peter Vandenberghe5, Eric Delabesse6, Tim Lammens7, Barbara De Moerloose7, Björn Menten1, Nadine Van Roy1, Bruno Verhasselt8, Bruce Poppe1, Yves Benoit7, Tom Taghon8, Ari M Melnick3, Frank Speleman1, Hans-Guido Wendel2, Pieter Van Vlierberghe1.   

Abstract

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive form of leukemia that is mainly diagnosed in children and shows a skewed gender distribution toward males. In this study, we report somatic loss-of-function mutations in the X-linked histone H3K27me3 demethylase ubiquitously transcribed X (UTX) chromosome, in human T-ALL. Interestingly, UTX mutations were exclusively present in male T-ALL patients and allelic expression analysis revealed that UTX escapes X-inactivation in female T-ALL lymphoblasts and normal T cells. Notably, we demonstrate in vitro and in vivo that the H3K27me3 demethylase UTX functions as a bona fide tumor suppressor in T-ALL. Moreover, T-ALL driven by UTX inactivation exhibits collateral sensitivity to pharmacologic H3K27me3 inhibition. All together, our results show how a gender-specific and therapeutically relevant defect in balancing H3K27 methylation contributes to T-cell leukemogenesis.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25320243      PMCID: PMC4347284          DOI: 10.1182/blood-2014-05-577270

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

1.  A histone H3 lysine 27 demethylase regulates animal posterior development.

Authors:  Fei Lan; Peter E Bayliss; John L Rinn; Johnathan R Whetstine; Jordon K Wang; Shuzhen Chen; Shigeki Iwase; Roman Alpatov; Irina Issaeva; Eli Canaani; Thomas M Roberts; Howard Y Chang; Yang Shi
Journal:  Nature       Date:  2007-09-12       Impact factor: 49.962

2.  KDM6A point mutations cause Kabuki syndrome.

Authors:  Noriko Miyake; Seiji Mizuno; Nobuhiko Okamoto; Hirofumi Ohashi; Masaaki Shiina; Kazuhiro Ogata; Yoshinori Tsurusaki; Mitsuko Nakashima; Hirotomo Saitsu; Norio Niikawa; Naomichi Matsumoto
Journal:  Hum Mutat       Date:  2012-10-17       Impact factor: 4.878

3.  Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia.

Authors:  K Lezon-Geyda; V Najfeld; E M Johnson
Journal:  Leukemia       Date:  2001-06       Impact factor: 11.528

4.  Deletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor development.

Authors:  Daniel T Johnson; Richard Luong; Suk Hyung Lee; Yue Peng; Atossa Shaltouki; Jane T Lee; Dong Lin; Yuzhuo Wang; Zijie Sun
Journal:  J Biol Chem       Date:  2012-12-28       Impact factor: 5.157

5.  Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma.

Authors:  Patrick S Tarpey; Sam Behjati; Susanna L Cooke; Peter Van Loo; David C Wedge; Nischalan Pillay; John Marshall; Sarah O'Meara; Helen Davies; Serena Nik-Zainal; David Beare; Adam Butler; John Gamble; Claire Hardy; Jonathon Hinton; Ming Ming Jia; Alagu Jayakumar; David Jones; Calli Latimer; Mark Maddison; Sancha Martin; Stuart McLaren; Andrew Menzies; Laura Mudie; Keiran Raine; Jon W Teague; Jose M C Tubio; Dina Halai; Roberto Tirabosco; Fernanda Amary; Peter J Campbell; Michael R Stratton; Adrienne M Flanagan; P Andrew Futreal
Journal:  Nat Genet       Date:  2013-06-16       Impact factor: 38.330

6.  EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation.

Authors:  Wendy Béguelin; Relja Popovic; Matt Teater; Yanwen Jiang; Karen L Bunting; Monica Rosen; Hao Shen; Shao Ning Yang; Ling Wang; Teresa Ezponda; Eva Martinez-Garcia; Haikuo Zhang; Yupeng Zheng; Sharad K Verma; Michael T McCabe; Heidi M Ott; Glenn S Van Aller; Ryan G Kruger; Yan Liu; Charles F McHugh; David W Scott; Young Rock Chung; Neil Kelleher; Rita Shaknovich; Caretha L Creasy; Randy D Gascoyne; Kwok-Kin Wong; Leandro Cerchietti; Ross L Levine; Omar Abdel-Wahab; Jonathan D Licht; Olivier Elemento; Ari M Melnick
Journal:  Cancer Cell       Date:  2013-05-13       Impact factor: 31.743

7.  Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.

Authors:  Adolfo A Ferrando; Donna S Neuberg; Jane Staunton; Mignon L Loh; Christine Huard; Susana C Raimondi; Fred G Behm; Ching Hon Pui; James R Downing; D Gary Gilliland; Eric S Lander; Todd R Golub; A Thomas Look
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743

8.  Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia.

Authors:  Kim De Keersmaecker; Zeynep Kalender Atak; Ning Li; Carmen Vicente; Stephanie Patchett; Tiziana Girardi; Valentina Gianfelici; Ellen Geerdens; Emmanuelle Clappier; Michaël Porcu; Idoya Lahortiga; Rossella Lucà; Jiekun Yan; Gert Hulselmans; Hilde Vranckx; Roel Vandepoel; Bram Sweron; Kris Jacobs; Nicole Mentens; Iwona Wlodarska; Barbara Cauwelier; Jacqueline Cloos; Jean Soulier; Anne Uyttebroeck; Claudia Bagni; Bassem A Hassan; Peter Vandenberghe; Arlen W Johnson; Stein Aerts; Jan Cools
Journal:  Nat Genet       Date:  2012-12-23       Impact factor: 38.330

9.  Female bias in Rhox6 and 9 regulation by the histone demethylase KDM6A.

Authors:  Joel B Berletch; Xinxian Deng; Di Kim Nguyen; Christine M Disteche
Journal:  PLoS Genet       Date:  2013-05-02       Impact factor: 5.917

Review 10.  The H3K27me3 demethylase UTX in normal development and disease.

Authors:  Joni Van der Meulen; Frank Speleman; Pieter Van Vlierberghe
Journal:  Epigenetics       Date:  2014-02-21       Impact factor: 4.528

View more
  87 in total

Review 1.  Epigenetics in myelodysplastic syndromes.

Authors:  Michael Heuser; Haiyang Yun; Felicitas Thol
Journal:  Semin Cancer Biol       Date:  2017-08-02       Impact factor: 15.707

Review 2.  X-chromosome inactivation and escape.

Authors:  Christine M Disteche; Joel B Berletch
Journal:  J Genet       Date:  2015-12       Impact factor: 1.166

Review 3.  MLL3/MLL4/COMPASS Family on Epigenetic Regulation of Enhancer Function and Cancer.

Authors:  Christie C Sze; Ali Shilatifard
Journal:  Cold Spring Harb Perspect Med       Date:  2016-11-01       Impact factor: 6.915

Review 4.  Epigenetic regulatory mutations and epigenetic therapy for multiple myeloma.

Authors:  Daphné Dupéré-Richer; Jonathan D Licht
Journal:  Curr Opin Hematol       Date:  2017-07       Impact factor: 3.284

5.  Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency.

Authors:  Carolyn D Hurst; Olivia Alder; Fiona M Platt; Alastair Droop; Lucy F Stead; Julie E Burns; George J Burghel; Sunjay Jain; Leszek J Klimczak; Helen Lindsay; Jo-An Roulson; Claire F Taylor; Helene Thygesen; Angus J Cameron; Anne J Ridley; Helen R Mott; Dmitry A Gordenin; Margaret A Knowles
Journal:  Cancer Cell       Date:  2017-11-13       Impact factor: 31.743

Review 6.  Histone demethylases in physiology and cancer: a tale of two enzymes, JMJD3 and UTX.

Authors:  Kelly Marie Arcipowski; Carlos Alberto Martinez; Panagiotis Ntziachristos
Journal:  Curr Opin Genet Dev       Date:  2016-05-03       Impact factor: 5.578

Review 7.  The genetics and mechanisms of T cell acute lymphoblastic leukaemia.

Authors:  Laura Belver; Adolfo Ferrando
Journal:  Nat Rev Cancer       Date:  2016-07-25       Impact factor: 60.716

Review 8.  X- and Y-Linked Chromatin-Modifying Genes as Regulators of Sex-Specific Cancer Incidence and Prognosis.

Authors:  Rossella Tricarico; Emmanuelle Nicolas; Michael J Hall; Erica A Golemis
Journal:  Clin Cancer Res       Date:  2020-07-30       Impact factor: 12.531

Review 9.  H3K27 Methylation: A Focal Point of Epigenetic Deregulation in Cancer.

Authors:  J N Nichol; D Dupéré-Richer; T Ezponda; J D Licht; W H Miller
Journal:  Adv Cancer Res       Date:  2016-06-17       Impact factor: 6.242

Review 10.  Lysine-specific histone demethylases in normal and malignant hematopoiesis.

Authors:  Jaclyn Andricovich; Yan Kai; Alexandros Tzatsos
Journal:  Exp Hematol       Date:  2016-05-18       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.